Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

Comparison of Two Different Lung Ultrasound Imaging Protocols in COVID -19 Pneumonia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04805684

Enrollment

Registered

2021-03-18

Start date

2021-01-01

Completion date

2021-03-05

Last updated

2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Lung Ultrasound, Pneumonia

Brief summary

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Detailed description

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Interventions

DEVICELUS Twelve area

Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

DEVICELUS Fourteen area

Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Investigator)

Masking description

The investigator was unaware of patient information such as medical history, PCR (polymerase chain reaction) test result, laboratory measurements, and CT scan results

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* 18 and 85 years old * Hospitalized in intensive care unit * PCR (polymerase chain reaction) tested * Thoracic CT applied

Exclusion criteria

* Previous lung operation * Thoracic wall disorder * Interstitial lung disease * Patients who did not consent to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Correlation between Thoracic CT imaging results and LUS results	6 hours	Lung ultrasonography will be performed within 6 hours of the Thoracic CT.

Secondary

Measure	Time frame	Description
Characteristics of lesions	6 hours	Identifying the characteristics of the abnormal findings detected in Thoracic CT and LUS

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026